Beractant Suppliers & Bulk Manufacturers

Available Forms: Intratracheal suspension

Available Strengths: 25 mg/mL

Reference Brands: Survanta(US & EU)

Category: Respiratory Disorder

Beractant is available in Intratracheal suspension and strengths such as 25 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Beractant is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Beractant can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Beractant, marketed as Survanta, is a bovine-derived pulmonary surfactant used for the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants. Each mL contains 25 mg of phospholipids, available in 4 mL (100 mg) and 8 mL (200 mg) single-use vials. Beractant is administered via intratracheal instillation to reduce surface tension in the lungs and improve neonatal respiratory function. Approved by the FDA and widely used in the US and EU, Survanta is a critical product in NICUs worldwide. Trusted by neonatologists, it is a top-choice surfactant for neonatal care and B2B sourcing.